» Authors » Haci Hasan Yeter

Haci Hasan Yeter

Explore the profile of Haci Hasan Yeter including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 43
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Aktepe O, Gundogdu F, Kosemehmetoglu K, Yeter H, Aksoy S, Guven D, et al.
Ir J Med Sci . 2021 Sep; 191(4):1561-1567. PMID: 34472040
Background: The association of thrombospondin type 1 domain-containing 7A (THSD7A) expression, a novel angiogenesis-related marker, with survival outcomes of tumors including renal cell carcinoma (RCC) remains to be clarified. Therefore,...
12.
Yasar E, Ozger H, Yeter H, Yildirim C, Osmanov Z, Cetin T, et al.
Int Urol Nephrol . 2021 Jul; 54(3):627-636. PMID: 34213713
Purpose: To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. Methods: The study...
13.
Akcay O, Yeter H, Karcaaltincaba D, Bayram M, Guz G, Erten Y
Clin Transplant . 2021 May; 35(8):e14349. PMID: 33978259
Background: Kidney transplantation (KT) is the best option for many women with end-stage renal disease desiring pregnancy. The aim of this study was to investigate obstetric and graft outcomes among...
14.
Aktepe O, Guner G, Guven D, Taban H, Yildirim H, Sahin T, et al.
Turk J Urol . 2021 Apr; 47(2):113-119. PMID: 33819441
Objective: The albumin to globulin ratio (AGR) has been demonstrated to be associated with survival outcomes in various tumor types. However, the prognostic value of AGR in patients with metastatic...
15.
Helvaci O, Korucu B, Yeter H, Gonen S, Helvaci B, Sanisoglu Y, et al.
Exp Clin Transplant . 2021 Mar; 21(11):872-878. PMID: 33641658
Objectives: Incidence of new-onset diabetes after transplant negatively affects graft and patient survival. Obesity, impaired fasting glucose before transplant, and a history of diabetes in first-degree relatives are well-defined risk...
16.
Aktepe O, Guven D, Sahin T, Yildirim H, Celikten B, Yeter H, et al.
Nutr Cancer . 2021 Jan; 73(10):1957-1963. PMID: 33491495
Background: We aimed to investigate the prognostic value of red cell distribution width (RDW) in metastatic renal cell carcinoma (mRCC) patients treated with targeted therapy, including sunitinib and pazopanib. Methods:...
17.
Akcay O, Yeter H, Buyukasik Y
Rom J Intern Med . 2020 May; 58(3):138-145. PMID: 32452194
Background: After the inclusion of all-trans retinoic acid (ATRA) into the treatment of Acute Promyelocytic leukemia (APL), a notable improvement concerning the survival rates of patients with APL has been...